1. A safety and clinical efficacy analysis of PCSK9 monoclonal antibodies in patients with markedly elevated creatine phosphokinase levels. (14th October 2021) Authors: Zafrir, B; Hislop, E; Volis, I; Saliba, W Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute arterial events across all vascular territories in the FOURIER trial. (14th October 2021) Authors: Oyama, K; Giugliano, R; Tang, M; Bonaca, M; Saver, J; Murphy, S; Ruzza, A; Sever, P; Sabatine, M; Bergmark, B Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adherence to high-intensity statin therapy after acute coronary syndrome and its impact on patient outcome. (25th November 2020) Authors: Sulzgruber, P; Sinkovec, H; Kazem, N; Hofer, F; Hammer, A; Koller, L; Todorovic, M; Katsch, F; Gall, W; Duftschmid, G; Heinze, G; Niessner, A Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in markers of subclinical atherosclerosis in patients with familial hypercholesterolemia treated with evolocumab: a prospective cohort study. (25th November 2020) Authors: Calcaterra, I; Di Minno, A; Gentile, M; Tripaldella, M; Buonaiuto, A; Forte, F; Di Taranto, M.D; Giacobbe, C; Iannuzzo, G; Rubba, P.O.F; Di Minno, M.N.D Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical efficacy and safety outcomes of bempedoic acid for LDL-C lowering therapy in patients at high cardiovascular risk: a systematic review and meta-analysis. (14th October 2021) Authors: Lin, Y; Parco, C; Karathanos, A; Krieger, T; Schulze, V; Chernyak, N; Icks, A; Kelm, M; Brockmeyer, M; Wolff, G Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Clinical factors, psychological factors and beliefs about statin use in patients with coronary heart disease and self-perceived muscle side-effects. (25th November 2020) Authors: Peersen, K; Sverre, E; Kristiansen, O; Fagerland, M; Gullestad, L; Otterstad, J.E; Dammen, T; Munkhaugen, J Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Correlation between different LDL-R mutations and response to ab-PCSK9 therapy in a group of patient with genetic diagnosis of Familial Hypercholesterolemia. Preliminary report. (25th November 2020) Authors: Buonaiuto, A; Gentile, M; Calcaterra, I.L; Giacobbe, C; Tripaldella, M; Forte, F; Iannuzzo, G; Di Minno, M.N.D; Fortunato, G; Rubba, P.O.F Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Dose-dependent effects of rosuvastatin on circulating microRNAs-27a and 221 levels in patients with coronary artery disease with type 2 diabetes mellitus. (14th October 2021) Authors: Serik, S; Riabukha, V; Serdobinska-Kanivets, E; Bondar, T; Ovrakh, T Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Effect of statins on mortality in patients with COVID-19: an updated meta-analysis of 147824 patients. (14th October 2021) Authors: Diaz-Arocutipa, C; Melgar-Talavera, B; Saravia-Bartra, M; Cazorla, P; Belzusarri, I; Alvarado-Yarasca, A; Hernandez, A V Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effects of evolocumab on plasma levels of proprotein convertase subtilisin/kexin type 9 and lipoprotein(a) in acute myocardial infarction. (25th November 2020) Authors: Nakamura, A; Kanazawa, M; Kagaya, Y; Kondo, M; Sato, K; Endo, H; Nozaki, E Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗